Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B

Journal of Immunological Methods

Volumn 237, Issue 1-2, 2000, Pages 73-84

  Plested, Joyce S ^a,b   Gidney, Margaret Anne J ^c   Coull, Philip A ^a,b   Griffiths, Helen G ^b   Herbert, Mark A ^a   Bird, A Graham ^d   Richards, James C ^c   Moxon, E Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

ELISA; GalE mutant; IgG; IgM; Inner core LPS; Neisseria meningitidis

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; OUTER MEMBRANE PROTEIN;

ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; INFANT; MUTANT; NEISSERIA MENINGITIDIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REPRODUCIBILITY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; CARBOHYDRATE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, BACTERIAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; LIPOPOLYSACCHARIDES; MENINGOCOCCAL INFECTIONS; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA MENINGITIDIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROTYPING;

GALE; MURINAE; NEISSERIA; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP B;

EID: 0034599411     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00142-3     Document Type: Article

References (30)

1. Abdillahi H., Poolman J.T. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48:1987;367-371.
2. Abdillahi H., Poolman J.T. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:1988;177-180.
3. Bjune G., Hoiby E.A., Gronnesby J.K., Arnesen O., Fredriksen J.H., Halstensen A., Holten E., Lindbak A.K., Nokelby H., Rosenqvist E. Effect of an outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 338:1991;1093-1096.
4. Boslego J., Garcia J., Cruz C., Zollinger W., Brandt B., Ruiz S., Martinez M., Arthur J., Underwood P., Silva W. Efficacy, safety, and immunogenicity of meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique. Chile. Vaccine. 13:1995;821-829.
5. Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine. 16:1998;1391-1395.
6. Carlin N.I., Gidney M.A., Lindberg A.A., Bundle D.R. Characterisation of Shigella flexneri-specific murine monoclonal antibodies by chemically defined glycoconjugates. J. Immunol. 137:1986;2361-2366.
7. CDR (1997) April Communicable Disease Weekly Report 7, no.14.
8. De Moraes J.C., Perkins B.A., Camargo M.C., Hidalgo N.T., Barbosa H.A., Sacchi C.T., Landgraf I.M., Gattas V.L., Vasconcelos D.G., Gral I.M. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo. Brazil. Lancet. 340:1992;1074-1078.
9. Estabrook M.M., Mandrell R.E., Apicella M.A., McLeod Griffiss J. Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide. Infect. Immunol. 58:1990;2204-2213.
10. Estabrook M.M., Baker C.J., McLeod Griffiss J. The Immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes. J. Infect. Dis. 167:1993;966-970.
11. Finne J., Leinonen M., Makela P.H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 2:1983;355-357.
12. Holten E. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six-months of 1978. J. Clin. Microbiol. 9:1979;186-188.
13. Jennings M.P., Hood D.W., Peak I.R., Virji M., Moxon E.R. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccaride structure in Neisseria meningitidis. Mol. Microbiol. 18:1995;729-740.
14. Jennings M.P., Bisercic M., Dunn K.L., Virji M., Martin A., Wilks K.E., Richards J.C., Moxon E.R. Cloning and molecular analysis of the lsi 1 (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells. Microb. Path. 19:1995;391-407.
15. Jennings M.P., van der Ley P., Wilks K.E., Maskell D.J., Poolman J., Moxon E.R. Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis. Mol. Microbiol. 10:1993;361-369.
16. Maiden M.C.J., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I., Achtman M., Spratt B.G. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. PNAS. 95:1998;3140-3145.
17. Masoud H., Moxon E.R., Martin A., Krajcarski D., Richards J.C. Structure of the variable and conserved lipopolysaccharide epitopes expressed by Haemophilus influenzae serotype b Eagan. Biochemistry. 36:1997;2091-2103.
18. Moxon E.R., Hood D., Richards J. Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections. Adv. Exp. Med. Biol. 435:1998;237-243.
19. Nassif X., Marceau X., Pujol C., Pron B., Beretti J. L, Taha M.K. Type 4-pili and meningococcal adhesiveness. Gene. 192:1997;149-153.
20. Perkins B.A., Jonsdottir K., Briem H., Griffiths E., Plikaytis B.D., Hoiby E.A., Rosenqvist E., Holst J., Nokelby H., Sotolongo F., Sierra G., Campa H.C., Carlone G.M., Williams D., Dykes J., Kapczynski D., Tikhomirov E., Wenger J.D., Broome C.V. Immunogenicity of two effacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177:1998;683-691.
21. Plested J.S., Makepeace K., Jennings M.P., Gidney M.A.J., Lacelle S., Brisson J-R., Cox A.D., Martin A., Bird A.G., Tang C.M., Mackinnon F.M., Richards J.C., Moxon E.R. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect. Immunol. 67:(10):1999;5417-5426.
22. Pollard A.J., Galassini R., Rouppe van der Voort E.M., Booy R., Langford P., Nadel S., Ison C., Kroll J.S., Poolman J.T., Levin M. Humoral immune responses to Neisseria meningitidis in children. Infect. Immunol. 67:1999;2441-2451.
23. Poolman J.T. Bacterial outer membrane protein vaccines. The meningococcal example. Adv. Exp. Med. Biol. 397:1996;73-77.
24. Preston A., Mandrell R.E., Gibson B.W., Apicella M.A. The lipooligosaccharides of pathogenic Gram-negative bacteria. Crit. Rev. Microbiol. 22:1996;139-180.
25. Shulman M., Wilde C.D., Kohler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 276:1978;269-270.
26. Sierra G.V., Campa H.C., Varcacel N.M., Garcia I.L., Izquierdo P.L., Sotolongo P.F., Casanueva G.V., Rico C.O., Rodriguez C.R., Terry M.H. Vaccine against group B Neisseria meningitidis protection trial and mass vaccination results in Cuba. NIPH Ann. 14:1991;195-210.
27. Van der ley P., Kramer M., Steeghs L., Kuipers B., Andersen S.R., Jennings M.P., Moxon E.R., Poolman J.T. Identification of a locus involved in meningococcal lipopolysaccharide biosynthesis by deletion mutagenesis. Mol. Microbiol. 19:1996;1117-1125.
28. Verheul A.F., Snippe H., Poolman J.T. Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol. Rev. 57:1993;34-49.
29. Wakarchuk W., Martin A., Jennings M.P., Moxon E.R., Richards J.C. Functional relationships of the genetic locus encoding the glycoosyltransferase enzymes involved in the expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. J. Biol. Chem. 271:1996;19166-19173.
30. Westphal O., Jann J.K. Bacterial lipopolysaccharides extraction with hot-phenol and further applications of the procedure. Meth. Carbohyd. Chem. 5:1965;83-91.